Ultraviolet radiation and the external eye

International Ophthalmology Clinics

Volumn 45, Issue 1, 2005, Pages 49-54

  Friedlaender, Mitchell H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; SUNSCREEN; THIOTEPA;

BASAL CELL CARCINOMA; CLIMATIC DROPLET KERATOPATHY; CONJUNCTIVA DISEASE; EYE INJURY; GENE MUTATION; HUMAN; KERATOCONJUNCTIVITIS; KERATOPATHY; PATHOPHYSIOLOGY; PHOTOAGING; PHOTOKERATOCONJUNCTIVITIS; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; PTERYGIUM; RADIATION PROTECTION; REVIEW; ULTRAVIOLET RADIATION;

CONJUNCTIVA; CORNEA; EYE DISEASES; EYELIDS; HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIATION INJURIES; RADIATION PROTECTION; SKIN; ULTRAVIOLET RAYS;

EID: 13244256906     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23:195-228.
2. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999;6:219-228.
3. Cornand G. Pterygium. Clinical course and treatment. Rev Int Track Pathol Ocul Trop Subtrop Sante Publique. 1989;66:31-108.
4. Taylor HR. Ultraviolet radiation and the eye: an epidemiologic study. Trans Am Ophthalmol Soc. 1989;87:802-853.
5. Taylor HR, West SK, Rosenthal FS, et al. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol. 1989;107:1481-1484.
6. Taylor HR, West S, Munoz B, et al. The long-term effects of visible light on the eye. Arch Ophthalmol. 1992;110:99-104.
7. Al-Bdour M, Al-Latayfeh MM. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand. 2004;82:64-67.
8. Tang FC, Chen SC, Lee HS, et al. Relationship between pterygium/pinguecula and sunlight exposure among postmen in central Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 1999;62:496-502.
9. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1998;26(Suppl 1):S2-S5.
10. Lim R, Mitchell P, Cumming RG. Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study. Am J Ophthalmol. 1998;126:717-719.
11. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in pterygium. Cancer Lett. 2004;206:77-83.
12. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res. 1997;16:1179-1192.
13. Tsironi S, Ioachim E, Machera M, et al. Immunohistochemical HLA-DR antigen expression with lymphocyte subsets and proliferative activity in pterygium. In Vivo. 2002;16:299-306.
14. Sakoonwatanyoo P, Tan DT, Smith DR. Expression of p63 in pterygium and normal conjunctiva. Cornea. 2004;23:67-70.
15. Naib-Majani W, Eltohami I, Wernert N, et al. Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefes Arch Clin Exp Ophthalmol. 2004;242:332-338.
16. Dushku N, Hatcher SL, Albert DM, et al. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol. 1999;117:1593-1599.
17. Nakaishi H, Yamamoto M, Ishida M, et al. Pingueculae and pterygia in motorcycle policemen. Ind Health. 1997;35:325-329.
18. Bergmanson JP, Soderberg PG. The significance of ultraviolet radiation for eye diseases. A review with comments on the efficacy of UV-blocking contact lenses. Ophthalmic Physiol Opt. 1995;15:83-91.
19. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
20. Frucht-Pery J, Siganos CS, Solomon A, et al. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study. Am J Ophthalmol. 1999;127:148-152.
21. Frau E, Labetoulle M, Lautier-Frau M, et al. Corneo-conjunctival autograft transplantation for pterygium surgery. Acta Ophthalmol Scand. 2004;82:59-63.
22. Paryani SB, Scott WP, Wells JW Jr, et al. Management of pterygium with surgery and radiation therapy. The North Florida Pterygium Study Group. Int J Radiat Oncol Biol Phys. 1994;28:101-103.
23. Neal AJ, Irwin C, Hope-Stone HF. The role of strontium-90 beta irradiation in the management of pterygium. Clin Oncol (R Coll Radiol). 1991;3:105-109.
24. Olander K, Haik KG, Haik GM. Management of pterygia: should thiotepa be used? Ann Ophthalmol. 1978;10:853-862.
25. Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Surv Ophthalmol. 1992;36:241-253.
26. Matta CS, Tabbara KF, Cameron JA, et al. Climatic droplet keratopathy with corneal amyloidosis. Ophthalmology. 1991;98:192-195.
27. Badr IA, al-Rajhi A, Wagoner MD, et al. Phototherapeutic keratectomy for climatic droplet keratopathy, KKESH Excimer Laser Study Group. King Khaled Eye Specialist Hospital. J Refract Surg. 1996;12:114-122.
28. al-Rajhi AA, Cameron JA. Recurrence of climatic droplet keratopathy. Two case reports. Acta Ophthalmol Scand. 1996;74:642-644.
29. Bergmanson JP, Sheldon TM. Ultraviolet radiation revisited. CLAO J. 1997;23:196-204.
30. Erbagci Z, Erbagci I, Erkilic S. High incidence of demodicidosis in eyelid basal cell carcinomas. Int J Dermatol. 2003;42:567-571.
31. Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108:2088-2098.
32. Saari KM, Paavilainen V, Tuominen J, et al. Epidemiology of basal cell carcinoma of the eyelid in south-western Finland. Graefes Arch Clin Exp Ophthalmol. 2001;239:230-233.
33. Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology. 2004;111:631-636.
34. Seite S, Colige A, Piquemal-Vivenot P, et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed. 2000;16:147-155.
35. Scherschun L, Lim HW. Photoprotection by sunscreens. Am J Clin Dermatol. 2001;2:131-134.
36. Naylor MF, Farmer KC. The case for sunscreens. A review of their use in preventing actinic damage and neoplasia. Arch Dermatol. 1997;133:1146-1154.
37. Scherschun L, Lim HW. Photoprotection by sunscreens. Am J Clin Dermatol. 2001;2:131-134.
38. Cole C. Sunscreen protection in the ultraviolet A region: how to measure the effectiveness. Photodermatol Photoimmunol Photomed. 2001;17:2-10.